These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8633813)

  • 1. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine.
    Moore GM; Basson RP; Tonkinson LV
    Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy dose determination study of tilmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumoniae in swine.
    Moore GM; Mowrey DH; Tonkinson LV; Lechtenberg KF; Schneider JH
    Am J Vet Res; 1996 Feb; 57(2):220-3. PubMed ID: 8633812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine.
    Paradis MA; Vessie GH; Merrill JK; Dick CP; Moore C; Charbonneau G; Gottschalk M; MacInnes JI; Higgins R; Mittal KR; Girard C; Aramini JJ; Wilson JB
    Can J Vet Res; 2004 Jan; 68(1):7-11. PubMed ID: 14979429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
    Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
    J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs.
    Fittipaldi N; Klopfenstein C; Gottschalk M; Broes A; Paradis MA; Dick CP
    Can J Vet Res; 2005 Apr; 69(2):146-50. PubMed ID: 15971680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effectiveness of tilmicosin in respiratory diseases of swine].
    Binder S; Le NB; Berner H; Bauer J
    Berl Munch Tierarztl Wochenschr; 1993 Jan; 106(1):6-9. PubMed ID: 8431202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental infections with Actinobacillus pleuropneumoniae in pigs--II. Comparison of antibiotics for oral strategic treatment.
    Wallgren P; Segall T; Pedersen Mörner A; Gunnarsson A
    Zentralbl Veterinarmed B; 1999 May; 46(4):261-9. PubMed ID: 10379236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tilmicosin phosphate (Pulmotil premix) in feed for the treatment of a clinical outbreak of Actinobacillus pleuropneumoniae infection in growing-finishing pigs.
    Hoflack G; Maes D; Mateusen B; Verdonck M; de Kruif A
    J Vet Med B Infect Dis Vet Public Health; 2001 Nov; 48(9):655-64. PubMed ID: 11765801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs.
    Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB
    Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526
    [No Abstract]   [Full Text] [Related]  

  • 10. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
    Shryock TR; Staples JM; DeRosa DC
    J Vet Diagn Invest; 2002 Sep; 14(5):389-95. PubMed ID: 12296390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental model of swine pneumonic pasteurellosis using crude Actinobacillus pleuropneumoniae cytotoxin and Pasteurella multocida given endobronchially.
    Chung WB; Bäckström LR; Collins MT
    Can J Vet Res; 1994 Jan; 58(1):25-30. PubMed ID: 8143249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral administration of tilmicosin on pulmonary inflammation in piglets experimentally infected with Actinobacillus pleuropneumoniae.
    Nerland EM; LeBlanc JM; Fedwick JP; Morck DW; Merrill JK; Dick P; Paradis MA; Buret AG
    Am J Vet Res; 2005 Jan; 66(1):100-7. PubMed ID: 15691043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics.
    Stipkovits L; Miller D; Glavits R; Fodor L; Burch D
    Can J Vet Res; 2001 Oct; 65(4):213-22. PubMed ID: 11768127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs, following experimental challenge with A. pleuropneumoniae, Mycoplasma hyopneumoniae and Pasteurella multocida.
    Eamens GJ; Gonsalves JR; Whittington AM; Turner B
    Aust Vet J; 2012 Jun; 90(6):225-34. PubMed ID: 22632286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demonstration of pneumonia in swine as a constant problem: culture and immunofluorescence microscopic studies of bronchioalveolar lavage (BAL) and serological findings].
    Runge M; Ganter M; Delbeck F; Hartwick W; Rüffer A; Franz B; Amtsberg G
    Berl Munch Tierarztl Wochenschr; 1996 Mar; 109(3):101-7. PubMed ID: 8721303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
    Dayao D; Gibson JS; Blackall PJ; Turni C
    Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
    Blondeau JM; Fitch SD
    PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of calf pneumonia with tilmicosin.
    Fodor L; Varga J; Gallowitsch F; Horváth-Papp I; Miklós G; Lajcsák A; Harmath A
    Acta Vet Hung; 1993; 41(1-2):41-9. PubMed ID: 8116500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of florphenicol premix in weanling pigs experimentally infected with Actinobacillus pleuropneumoniae.
    Palacios-Arriaga JM; Gutierrez-Pabello JA; Chavez-Gris G; Hernandez-Castro R
    Rev Latinoam Microbiol; 2000; 42(1):27-33. PubMed ID: 10948826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.